Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Central muscarinic receptor agonists patented by U. of Toledo

Dec. 7, 1998

Zomig copromoted by Cephalon in the U.K.

Dec. 4, 1998

Heterocyclic melatonergic agents designed at ADIR

Dec. 4, 1998

Harris FRC establishes safety of candidate antiepileptic drug in volunteer studies

Dec. 3, 1998

Final marketing application filed for Ampligen in E.U.

Dec. 3, 1998

Significant protection against ischemic injury in cortex of rats primed with estradiol

Dec. 3, 1998

Gene therapies for neuromuscular diseases pursued by Transgene and AFM

Dec. 2, 1998

ABS receives funding from NIH to support development of Alzheimer's drug

Dec. 1, 1998

Piperidine derivatives from Sanofi useful for neurokinin-dependent pathologies

Dec. 1, 1998

Orion launches entacapone in first markets and updates safety information

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.